Does Humana Pay for GLP-1 Medications? (2026)
Humana covers GLP-1 medications only in limited cases; prior authorization is required, and what an approved member pays depends on the plan.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Where Each Medication Stands[5]
| Medication | What Humana does |
|---|---|
| Wegovy (semaglutide) | Humana no longer sells employer commercial medical plans: it finalized that exit in 2025, per its 10-K. This row reads its Medicare lists. The 2026 individual Medicare drug lists we read (Gold Plus HMO, HumanaChoice PPO, Value Rx PDP, updated 10/01/2026) do not list Wegovy. The 2027 lists we read (Gold Plus HMO, Basic Rx and Value Rx PDP, updated 10/12/2026) add the pens and tablets at Tier 3 with PA and a quantity limit. Employer retiree lists differ: Formulary 26800 has Wegovy at Tier 4 with PA for 2026, and Formulary 27800 has it at Tier 2 with PA and a quantity limit for 2027. Humana says standard Part D plans don't cover GLP-1 drugs only for weight loss, while Part D may cover Wegovy prescribed for diabetes or cardiovascular disease. Weight-loss use runs through the Medicare GLP-1 Bridge, outside the plan. Lists vary by plan, and these are the ones we read. |
| Ozempic (semaglutide) | Covered for type 2 diabetes diagnosis on most Humana plans. |
| Zepbound (tirzepatide) | Not on the 2026 or 2027 individual Medicare lists we read; a member can ask Humana for a formulary exception. Employer retiree lists differ: Formulary 26800 (2026) has the pen and solution at Tier 4 with PA and the KwikPen at Tier 3 with PA and a quantity limit, and Formulary 27800 (2027) has only the KwikPen row, at Tier 3 with PA and a quantity limit. Part D excludes weight-loss-only use; the Medicare GLP-1 Bridge is separate. |
| Mounjaro (tirzepatide) | Tier 3 with PA and a quantity limit (2 per 28 days) on the 2026 and 2027 individual Medicare lists we read, and Tier 2 with PA and the same limit on the employer retiree lists. Those lists show no step-therapy flag. |
| Copay when it is covered | Varies by plan and tier |
What a GLP-1 costs a Humana member
When Humana covers the drug, a manufacturer savings card can bring a Wegovy or Zepbound fill down to $25, with each maker paying at most $100 a month.
After a Denial from Humana
A Humana denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.
If a large employer self-funds your Humana plan, ERISA rather than state insurance law applies and the employer decides whether anti-obesity drugs are covered[2]; the Summary Plan Description says which.
Where to go if Humana says no
The 8 cheapest cash-pay compounded GLP-1s
| # | Seller | Monthly price | Score | Visit |
|---|---|---|---|---|
| 1 | WellMedRx Compounded semaglutide | $49/mo | 6.3 | Visit |
| 2 | Collective Compounded semaglutide | $59/mo | 9.1 | Visit |
| 3 | RenewlyRX Compounded semaglutide | $68/mo | 6.6 | Review |
| 4 | Lean Meds Compounded semaglutide | $79/mo | 9.4 | Review |
| 5 | Tryozi Compounded semaglutide | $79/mo | 9.4 | Review |
| 6 | Embody Compounded semaglutide | $79/mo | 9.3 | Visit |
| 7 | NextMeds Compounded semaglutide | $79/mo | 9.3 | Review |
| 8 | CoreAge Rx Compounded semaglutide | $79/mo | 9.0 | Visit |
Top-rated sellers that bill insurance
23 sellers say they accept insurance. Confirm with the seller that it bills Humana before you book.
| # | Seller | Cash price | Score | Visit |
|---|---|---|---|---|
| 1 | NovoCare Pharmacy | $149/mo | 7.9 | Review |
| 2 | Ivim Health | $140/mo | 7.3 | Visit |
| 3 | Thrivelab | $175/mo | 6.9 | Review |
| 4 | Spry | $199/mo | 6.8 | Review |
| 5 | Calibrate Health | Price not published | 6.7 | Review |
Every seller and price, side by side: compare all sellers.
Frequently Asked Questions
Humana no longer sells employer commercial medical plans: it finalized that exit in 2025, per its 10-K. This row reads its Medicare lists. The 2026 individual Medicare drug lists we read (Gold Plus HMO, HumanaChoice PPO, Value Rx PDP, updated 10/01/2026) do not list Wegovy. The 2027 lists we read (Gold Plus HMO, Basic Rx and Value Rx PDP, updated 10/12/2026) add the pens and tablets at Tier 3 with PA and a quantity limit. Employer retiree lists differ: Formulary 26800 has Wegovy at Tier 4 with PA for 2026, and Formulary 27800 has it at Tier 2 with PA and a quantity limit for 2027. Humana says standard Part D plans don't cover GLP-1 drugs only for weight loss, while Part D may cover Wegovy prescribed for diabetes or cardiovascular disease. Weight-loss use runs through the Medicare GLP-1 Bridge, outside the plan. Lists vary by plan, and these are the ones we read.
Covered for type 2 diabetes diagnosis on most Humana plans.
Not on the 2026 or 2027 individual Medicare lists we read; a member can ask Humana for a formulary exception. Employer retiree lists differ: Formulary 26800 (2026) has the pen and solution at Tier 4 with PA and the KwikPen at Tier 3 with PA and a quantity limit, and Formulary 27800 (2027) has only the KwikPen row, at Tier 3 with PA and a quantity limit. Part D excludes weight-loss-only use; the Medicare GLP-1 Bridge is separate.
Tier 3 with PA and a quantity limit (2 per 28 days) on the 2026 and 2027 individual Medicare lists we read, and Tier 2 with PA and the same limit on the employer retiree lists. Those lists show no step-therapy flag.
Humana does not publish one copay; it depends on the plan.
Appeal first: ask Humana for the written denial and the criteria it applied, and have your prescriber answer them in a letter of medical necessity. If the appeal fails, the cheapest cash route is compounded semaglutide or tirzepatide, from WellMedRx at $49/mo or Collective at $59/mo. 23 sellers say they bill insurance. A compounded drug is not FDA-approved as a finished product.
Glossary
The words sellers use, defined. Tap any term.
- Prior authorization (PA) · Insurance and regulatory
- Step therapy · Insurance and regulatory
- PBM (Pharmacy Benefit Manager) · insurance
- Formulary tier · Insurance and regulatory
- Copay accumulator · insurance
- Manufacturer coupon · insurance
- Quantity limit · insurance
Sources & methodology — as of November 2026
- 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
- 2.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
- 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.